Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. 1038915-73-9
2. Mk-4827 Tosylate
3. Mk-4827 (tosylate)
4. Mk-4827-tosylate
5. Niraparib (tosylate)
6. Mk 4827 Tosylate
7. Niraparib (mk-4827) Tosylate
8. (s)-2-(4-(piperidin-3-yl)phenyl)-2h-indazole-7-carboxamide 4-methylbenzenesulfonate
9. 75ke12ay9u
10. Mk-4827(niraparib) Tosylate
11. 2h-indazole-7-carboxamide, 2-(4-(3s)-3-piperidinylphenyl)-, 4-methylbenzenesulfonate (1:1)
12. Unii-75ke12ay9u
13. Niraparib Tosylate Monohyrate
14. Niraparib(mk-4827) Tosylate
15. Schembl20522624
16. Dtxsid801026487
17. Hy-10619b
18. Mfcd28167748
19. S7625
20. Ccg-269634
21. Niraparib Tosylate [orange Book]
22. Ac-30383
23. As-56981
24. A11848
25. A909268
26. Q27266392
27. (3s)-3-[4-[7-(aminocarbonyl)-2h-indazol-2-yl]phenyl]piperidine Tosylate
28. (s)-2-(4-(piperidin-3-yl)phenyl)-2h-indazole-7-carboxamide 4-?methylbenzenesulfona?te
29. 4-methylbenzenesulfonic Acid;2-[4-[(3s)-piperidin-3-yl]phenyl]indazole-7-carboxamide
30. 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide; 4-methylbenzene-1-sulfonic Acid
Molecular Weight | 492.6 g/mol |
---|---|
Molecular Formula | C26H28N4O4S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 492.18312656 g/mol |
Monoisotopic Mass | 492.18312656 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 655 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : Yes
TE Code :
Brand Name : ZEJULA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2017-03-27
Application Number : 208447
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : ZEJULA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2023-04-26
Application Number : 214876
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : ZEJULA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Approval Date : 2023-04-26
Application Number : 214876
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : ZEJULA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Approval Date : 2023-04-26
Application Number : 214876
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2038-03-27
US Patent Number : 11673877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214876
Patent Use Code : U-3647
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-03-27
Patent Expiration Date : 2027-08-12
US Patent Number : 8143241
Drug Substance Claim :
Drug Product Claim :
Application Number : 214876
Patent Use Code : U-2655
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-12
Patent Expiration Date : 2027-08-12
US Patent Number : 8071579
Drug Substance Claim :
Drug Product Claim :
Application Number : 208447
Patent Use Code : U-2655
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-12
Patent Expiration Date : 2029-04-24
US Patent Number : 8436185
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214876
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-24
Patent Expiration Date : 2029-04-24
US Patent Number : 8436185
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214876
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-24
Patent Expiration Date : 2038-03-27
US Patent Number : 11673877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214876
Patent Use Code : U-3646
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-03-27
Patent Expiration Date : 2027-08-12
US Patent Number : 8143241
Drug Substance Claim :
Drug Product Claim :
Application Number : 214876
Patent Use Code : U-2655
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-12
Patent Expiration Date : 2031-03-27
US Patent Number : 8071623
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208447
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-27
Patent Expiration Date : 2038-03-27
US Patent Number : 11673877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214876
Patent Use Code : U-3647
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-03-27
Patent Expiration Date : 2039-01-04
US Patent Number : 11730725
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214876
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-01-04
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?